levodopa has been researched along with vasoactive intestinal peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranowska, B; Borowiec, M; Radzikowska, M; Roguski, K; Wasilewska-Dziubinska, E | 1 |
1 other study(ies) available for levodopa and vasoactive intestinal peptide
| Article | Year |
|---|---|
The role of VIP and somatostatin in the control of GH and prolactin release in anorexia nervosa and in obesity.
Topics: Adolescent; Adult; Anorexia Nervosa; Case-Control Studies; Clonidine; Female; Gonadotropin-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Obesity; Prolactin; Somatostatin; Vasoactive Intestinal Peptide | 2000 |